Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

THE TRUTH ABOUT: Agilent technologies inc - The Untold Story

3 Specialty Healthcare Providers Addressing Niche Markets

The healthcare industry is poised for growth driven by the rapid adoption of new and advanced medical technologies to enhance diagnosis. Hence, investors might consider investing in healthcare stocks, such as Agilent Technologies (A), BioNTech (BNTX), and STERIS (STE), which address niche markets. Read more….

StockNews.com

3 Genomic Research Companies Pioneering Personalized Medicine

With vast potential, contribution to rare disease discovery and management, and adoption of AI, the genomic research market is thriving. Hence, fundamentally solid genomic research stocks Agilent Technologies (A), Illumina (ILMN), and 10x Genomics (TXG) could be ideal buys. Read more.

StockNews.com

Analyzing 2024 Gain Potential in 3 Medical Stocks

The medical sector is poised for substantial gains this year, fueled by rising cases of chronic diseases and swift technological progress. In light of this, let’s analyze the fundamentals of three medical stocks: Abbott Laboratories (ABT), Agilent Technologies (A), and Viemed Healthcare (VMD). Read on….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Uncovering the Investment Prospects of Agilent Technologies (A) and Medtronic (MDT)

The medical industry is poised for growth with technological advancements, increasing disease rates, and government support. Therefore, let's assess the investment prospects of leading medical stocks Agilent Technologies (A) and Medtronic (MDT). Read more….

StockNews.com

3 Medical Diagnostics Stocks to Buy Today

The medical diagnostics industry is well-positioned for growth due to technological advancements, rising incidence of diseases, and government support. To that end, it could be wise to buy fundamentally strong medical diagnostics stocks Agilent Technologies (A), Mettler-Toledo International (MTD), Harvard Bioscience (HBIO). Read more.

StockNews.com

3 'A' POWR Rated Medical Stocks to Buy

The growing adoption of automated medical platforms and rising government initiatives should bode well for the medical industry. Therefore, fundamentally strong medical stocks Agilent Technologies (A), Bruker (BRKR), and Semler Scientific (SMLR), which are A (Strong Buy) rated in our proprietary rating system, might be solid buys. Read on.

StockNews.com

3 Healthy Looking Stocks to Own This Week

The healthcare industry thrived during the pandemic and is well-positioned to remain buoyed amid rising healthcare spending and technological advancements. Given this backdrop, healthcare stocks Agilent Technologies (A), Bruker Corporation (BRKR), and Semler Scientific (SMLR) could be ideal buys. Read on.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

2 Stocks to Help You Build a Healthy Portfolio for the Long Term

Despite rampant economic headwinds, the U.S. job market remains tight and resilient. Although the uncertainties remain, investors should stay invested and focus on their long-term strategies. Therefore, quality stocks Pfizer (PFE) and Agilent Technologies (A) could be ideal picks to build a healthy portfolio for the long term. Keep reading….

StockNews.com

The 5 Best Stocks to Invest in for the Long Term

Despite current market uncertainties, the U.S. economy's long-term growth prospects are pretty viable. Experts believe inflation will fall dramatically in the coming year, and robust growth will follow. Therefore, investors could buy quality stocks Microsoft (MSFT), Vertex Pharmaceuticals (VRTX), Centene (CNC), Agilent Technologies (A), and Myers Industries (MYE), which seem…

StockNews.com

3 Under-The-Radar Stocks to Buy Now

With the markets anticipating further interest rate hikes and devoid of a clear sense of direction until then, fundamentally strong stocks Agilent Technologies (A), Canon (CAJ), and Hudson Global (HSON) may be appropriate additions to one’s portfolio as they are quietly creating value for their shareholders. Continue reading….

StockNews.com

2 Stocks That Could Be Bargain Buys for 2023

The October inflation report came in lower than expected, indicating that inflationary pressures are easing. The Fed is expected to slow the pace of rate hikes in the coming months. Moreover, investor interest in value stocks has increased significantly over the past month. Therefore, we think Oracle (ORCL) and Agilent…

StockNews.com

Don’t Miss out on the Gains in These 2 Stocks Right Now

The Fed’s aggressive rate hikes are slowing the economy and raising the odds of a recession. However, despite the economic uncertainties, staying invested could help garner significant returns in the long term. We believe fundamentally strong stocks Microsoft (MSFT) and Agilent Technologies (A) could be ideal long-term investments. Read more….

StockNews.com

3 Diagnostics & Research Stocks to Buy on the Dip

The diagnostics and research industry has witnessed significant growth over the past couple years due to the pandemic-driven tailwinds, growing prevalence of chronic diseases, and rising adoption of advanced technologies. Thus, shares of fundamentally-sound companies Agilent Technologies (A), Waters Corp. (WAT), and Laboratory Corporation of America Holdings (LH) could be…

StockNews.com

Analyzing Agilent Technologies Inc's Short Interest

Agilent Technologies Inc's (NYSE:A) short percent of float has fallen 6.71% since its last report. The company recently reported that it has 4.16 million shares sold short, which is 1.39% of all regular shares that are available for trading.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

FDA Warns Against Relying On Screening Tests For Prenatal Diagnosis

The U.S. FDA is warning that noninvasive prenatal screening (NIPS) tests may provide false results, such as stating a fetus may have a genetic abnormality when the fetus was healthy. FDA issues warning on possible false results from noninvasive prenatal screening tests. The agency noted that these tests, also known as…

Benzinga

Analyzing Agilent Technologies Inc's Short Interest

Agilent Technologies Inc's (NYSE:A) short percent of float has fallen 9.2% since its last report. The company recently reported that it has 4.42 million shares sold short, which is 1.48% of all regular shares that are available for trading.

StockNews.com

Take Advantage of These 5 'Strong Buy' Stocks Down More Than 10% YTD

Amid deepening supply disruptions and record-high inflation, expected aggressive federal interest rate increases, and the resurgence of COVID-19 cases have been driving market volatility. However, we think quality stocks Agilent (A), Olympus (OCPNY), F5 (FFIV), Jones Lang LaSalle (JLL), and United Therapeutics (UTHR), which are down more than 10% in…

Benzinga

Analyzing Agilent Technologies Inc's Short Interest

Agilent Technologies Inc's (NYSE:A) short percent of float has fallen 6.86% since its last report. The company recently reported that it has 4.89 million shares sold short, which is 1.63% of all regular shares that are available for trading.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Looking Into Agilent Technologies Inc's Recent Short Interest

Agilent Technologies Inc's (NYSE:A) short percent of float has risen 7.36% since its last report. The company recently reported that it has 5.24 million shares sold short, which is 1.75% of all regular shares that are available for trading.

Benzinga

Agilent's Q1 FY22 Earnings Beat Expectations, FY22 Guidance Surpass Street Estimates

Agilent Technologies Inc (NYSE: A) reported

Benzinga

(A) - Analyzing Agilent Technologies Inc's Short Interest

Agilent Technologies Inc's (NYSE:A) short percent of float has risen 14.79% since its last report. The company recently reported that it has 4.91 million shares sold short, which is 1.63% of all regular shares that are available for trading.

People

Kritika SarmahHer

727 stories

Dipanjan BanchurSince

722 stories

Steve Reitmeister

508 stories

Sristi Suman JayaswalThe

216 stories

Santanu RoyHaving

215 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Microsoft Corporation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.